Cannabis Conundrum: Demonstrating “Accepted Medical Use” in a Restricted Research Environment October 7, 2020 Delia Deschaine Federal 0 Comments By Delia Ann Deschaine and Megan Robertson U.S. cannabis businesses operate in an increasingly complex legal and regulatory environment. Many, if not most, of those complexities stem from marijuana’s classification in Schedule I of the federal Controlled Substances Act. That… Read More→
Fifty Years: How Marijuana Became Re-Legalized In America July 25, 2018 Allen St. Pierre Policy & Legal 0 Comments Part of a year-long series, longtime cannabis law reform advocate and historian Allen St. Pierre examines monthly for Cannabis Business Executive the last fifty years of cannabis prohibition and the public advocacy efforts in America to bring about the ongoing and… Read More→
D.C. Policy Summit – Researchers Working on First-Ever Federally-Approved Medical Marijuana Study Fighting to Overcome Significant DEA, NIDA Obstacles December 4, 2017 David Hodes Compliance and Regulations, Lab Testing 0 Comments The 10th Annual DuPont Summit on Science, Technology and Environment Policy held in Washington, D.C. on December 1 is usually reserved for issues like equitable access to broadband technology or building sustainability in policy or cybersecurity risk management. This year,… Read More→